BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12821945)

  • 41. p53's double life: transactivation-independent repression of homologous recombination.
    Bertrand P; Saintigny Y; Lopez BS
    Trends Genet; 2004 Jun; 20(6):235-43. PubMed ID: 15145576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene conversion is strongly induced in human cells by double-strand breaks and is modulated by the expression of BCL-x(L).
    Wiese C; Pierce AJ; Gauny SS; Jasin M; Kronenberg A
    Cancer Res; 2002 Mar; 62(5):1279-83. PubMed ID: 11888891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The tumor suppressor protein p53 stimulates the formation of the human topoisomerase I double cleavage complex in vitro.
    Søe K; Hartmann H; Schlott B; Stevnsner T; Grosse F
    Oncogene; 2002 Sep; 21(43):6614-23. PubMed ID: 12242659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Homologous recombination between p53 and its pseudogene in a radiation-induced mouse tumor.
    Tanooka H; Ootsuyama A; Sasaki H
    Cancer Res; 1998 Dec; 58(24):5649-51. PubMed ID: 9865715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluorescence-based quantification of pathway-specific DNA double-strand break repair activities: a powerful method for the analysis of genome destabilizing mechanisms.
    Böhringer M; Wiesmüller L
    Subcell Biochem; 2010; 50():297-306. PubMed ID: 20012588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of wild-type, S15D and R175H p53 proteins on DNA end joining in vitro: potential mechanism of DNA double-strand break repair modulation.
    Okorokov AL; Warnock L; Milner J
    Carcinogenesis; 2002 Apr; 23(4):549-57. PubMed ID: 11960905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leucine methylation of protein phosphatase PP4C at C-terminal is critical for its cellular functions.
    Lee J; Lee DH
    Biochem Biophys Res Commun; 2014 Sep; 452(1):42-7. PubMed ID: 25130464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombination at chromosomal sequences involved in leukaemogenic rearrangements is differentially regulated by p53.
    Boehden GS; Restle A; Marschalek R; Stocking C; Wiesmüller L
    Carcinogenesis; 2004 Aug; 25(8):1305-13. PubMed ID: 14742315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A function in apoptosis other than transactivation inherent in the NH2-terminal domain of p53.
    Theis S; Atz J; Mueller-Lantzsch N; Roemer K
    Int J Cancer; 1997 May; 71(5):858-66. PubMed ID: 9180157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of functional domains in the RAD51L2 (RAD51C) protein and its requirement for gene conversion.
    French CA; Tambini CE; Thacker J
    J Biol Chem; 2003 Nov; 278(46):45445-50. PubMed ID: 12966089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.
    Brady CA; Jiang D; Mello SS; Johnson TM; Jarvis LA; Kozak MM; Kenzelmann Broz D; Basak S; Park EJ; McLaughlin ME; Karnezis AN; Attardi LD
    Cell; 2011 May; 145(4):571-83. PubMed ID: 21565614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activities of wildtype and mutant p53 in suppression of homologous recombination as measured by a retroviral vector system.
    Lu X; Lozano G; Donehower LA
    Mutat Res; 2003 Jan; 522(1-2):69-83. PubMed ID: 12517413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2.
    Rajagopalan S; Andreeva A; Rutherford TJ; Fersht AR
    Proc Natl Acad Sci U S A; 2010 May; 107(19):8587-92. PubMed ID: 20421506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apoptosis and carcinogenesis.
    Wyllie AH; Bellamy CO; Bubb VJ; Clarke AR; Corbet S; Curtis L; Harrison DJ; Hooper ML; Toft N; Webb S; Bird CC
    Br J Cancer; 1999 Jul; 80 Suppl 1():34-7. PubMed ID: 10466759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The dual role model for p53 in maintaining genomic integrity.
    Janus F; Albrechtsen N; Dornreiter I; Wiesmüller L; Grosse F; Deppert W
    Cell Mol Life Sci; 1999 Jan; 55(1):12-27. PubMed ID: 10065148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contradiction between the expected role of tumour suppressor genes and the evolutionist theory.
    Nouri AM; Fowler GG
    Anticancer Res; 1998; 18(5A):3233-4. PubMed ID: 9858887
    [No Abstract]   [Full Text] [Related]  

  • 57. DNA uptake and repair enzyme access to transfected DNA is under reported by gene expression.
    Pastwa E; Lubner EM; Mezhevaya K; Neumann RD; Winters TA
    Biochem Biophys Res Commun; 2003 Jun; 306(2):421-9. PubMed ID: 12804580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relative Stability of Wild-Type and Mutant p53 Core Domain: A Molecular Dynamic Study.
    Rohani L; Morton DJ; Wang XQ; Chaudhary J
    J Comput Biol; 2016 Feb; 23(2):80-89. PubMed ID: 26675082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Take care of your chromosomes lest cancer take care of you.
    Maser RS; DePinho RA
    Cancer Cell; 2003 Jan; 3(1):4-6. PubMed ID: 12559169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parsing p53 Transactivation.
    Campisi J
    Dev Cell; 2011 May; 20(5):573-4. PubMed ID: 21571212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.